Canopy Growth (CGC) Enterprise Value (2017 - 2026)
Canopy Growth (CGC) reported Enterprise Value of -$265.9 million for Q1 2026, down 190.25% on a YoY basis from $294.7 million in Q1 2025, and down 15.96% sequentially from -$229.3 million in Q4 2025.
Canopy Growth (CGC) Enterprise Value (2017 - 2026) Analysis & Trends
Canopy Growth (CGC) has 10 years of Enterprise Value data on file, last reported at -$265.9 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value fell 190.25% year-over-year to -$265.9 million; the trailing twelve-month figure through Mar 2026 stood at -$265.9 million (down 190.25% YoY), and the FY2026 full-year result was -$265.9 million, down 190.25% from the prior year.
- Enterprise Value retreated to -$265.9 million in Q1 2026, from -$229.3 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$89.5 million in Q4 2024 to a low of -$1.1 billion in Q1 2022.
- A 5-year average of -$347.9 million and a median of -$187.1 million in 2023 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value surged 78.42% in 2023 and plunged 190.25% in 2026, its largest moves.
- Tracing CGC's Enterprise Value over 5 years: stood at -$580.7 million in 2022, then jumped by 76.47% to -$136.7 million in 2023, then soared by 34.53% to -$89.5 million in 2024, then sank by 156.33% to -$229.3 million in 2025, then declined by 15.96% to -$265.9 million in 2026.
- Business Quant data shows CGC's Enterprise Value at -$265.9 million in Q1 2026, -$229.3 million in Q4 2025, and -$94.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | -1.86 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -3.74 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -1.94 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -4.05 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -2.15 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -33.59 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -1.80 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -1.32 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -428.00 Mn |
| 10 | Canopy Growth | 197.77 Mn | -68.15 Mn | - | -265.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -265.93 Mn |
| Dec 31, 2025 | -229.33 Mn |
| Sep 30, 2025 | -94.07 Mn |
| Jun 30, 2025 | -95.29 Mn |
| Mar 31, 2025 | -91.62 Mn |
| Dec 31, 2024 | -89.47 Mn |
| Sep 30, 2024 | -172.93 Mn |
| Jun 30, 2024 | -146.12 Mn |
| Mar 31, 2024 | -131.70 Mn |
| Dec 31, 2023 | -136.65 Mn |
| Sep 30, 2023 | -187.10 Mn |
| Jun 30, 2023 | -402.62 Mn |
| Mar 31, 2023 | -412.07 Mn |
| Dec 31, 2022 | -580.71 Mn |
| Sep 30, 2022 | -866.99 Mn |
| Jun 30, 2022 | -932.55 Mn |
| Mar 31, 2022 | -1.08 Bn |
| Dec 31, 2021 | -1.13 Bn |
| Sep 30, 2021 | -596.16 Mn |
| Jun 30, 2021 | -357.04 Mn |